They are the licensed manufacturer and they own the assets, AND their own proprietary genetics bank to develop an unheard of 700 different strains of cannabis. This will cover any medicinal use imaginable to meet global market demand.
They are GMP certified and will be SGS certified in Q1. These certifications represent the highest standards for testing and quality in the industry.
The Medicinal Cannabis market is growing at 23.6% per year and they’re seeking additional investment capital to expand for continued rapid growth. This will be the ONLY offering prior to working exclusively with institutional investors. Lucky investors who get in now can get projected returns of over 5 TIMES your money!